Dr. Claudia Padilla discusses Alzheimer’s and a new treatment.

Claudia Padilla, MD, at Baylor Scott & White Health, discusses Alzheimer’s and a new treatment. What You Need to Know: Alzheimer’s disease is a type of dementia. The most common sign is short-term memory loss. New medication targets the protein…

Cerebral amyloid angiopathy, seizures, and epilepsy: Dr. Brin Freund

Sixty percent of patients with dementia on autopsy studies have cerebral amyloid angiopathy (CAA) pathology. This episode discusses the relationship between CAA and epilepsy through the lens of a recent publication. Dr. Alina Ivaniuk talks with Dr. Brin Freund.

$50 million gift to expand health sciences research at Virginia Tech

The Richmond, Virginia-based Red Gates Foundation recently committed $50 million to the Fralin Biomedical Research Institute at VTC to accelerate health sciences research at Virginia Tech. The gift is among the largest ever made to the university.

Dr. Liana Apostolova is available to comment on new results of a phase III clinical trial of Donanemab, an Alzheimer’s disease medication for patients with early symptoms of the disease.

Liana Apostolova, MD is the associate dean of Alzheimer’s disease research at Indiana University School of Medicine. Dr. Apostolova and others presented results of the phase 3 clinical trial of Donanemab at the Alzheimer’s Association International Conference. The study, also published…

Research Group Calls for Consensus, Collaboration to Improve Understanding of how Infections Drive Alzheimer’s

A research consortium, including a Philadelphia College of Osteopathic Medicine neuroscientist and his research coordinator, are calling for a consensus on how scientists identify and evaluate how infections contribute to or cause cognitive impairment and dementias, including Alzheimer’s disease.

Deep-brain stimulation during sleep strengthens memory

This study provides provides the first physiological evidence from inside the human brain supporting the dominant scientific theory on how the brain consolidates memory during sleep. Further, deep-brain stimulation during a critical time in the sleep cycle appeared to improve memory consolidation.

Alzheimer’s Drug Development Pipeline: Promising Therapies, Pharma Investment Drive Momentum in Clinical Trials

According to the newly released “Alzheimer’s Disease Drug Development Pipeline: 2023,” there are currently 187 clinical trials in the Alzheimer’s drug development pipeline – the most ever on record. This momentum is driven in part by greater investment from the pharma industry and a bump in biologic therapies – particularly monoclonal antibodies – that were central to the success of both recent FDA-approved drugs.

The annual report spots trends in clinical trial design and outcome measures, and also investigate the types of agents and biological targets that are being pursued.

High blood pressure in your 30s is associated with worse brain health in your 70s

New research from the UC Davis School of Medicine shows high blood pressure in early adulthood is associated with worse brain health in late life — especially for men. The results suggest that treating hypertension in young and middle-aged adults may help prevent dementia and Alzheimer’s disease.

MIND and Mediterranean Diets Associated with Fewer Alzheimer’s Plaques and Tangles

People who eat diets rich in green leafy vegetables as well as other vegetables, fruits, whole grains, olive oil, beans, nuts and fish may have fewer amyloid plaques and tau tangles in their brain—signs of Alzheimer’s disease—than people who do not consume such diets, according to a study published in the March 8, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

UC Davis study uncovers age-related brain differences in autistic individuals

Differences in genes involved in inflammation, immunity response and neural transmissions begin in childhood and evolve across the lifespan in brains of people with autism, a UC Davis MIND Institute has found.

Eartest by Eartone Application Detects Dementia Risk by Checking the Hearing of Words in Thai language

The Faculties of Medicine and Science, Chulalongkorn University, in collaboration with University College London (UCL), the United Kingdom, together with industrial partner have developed Eartest by Eartone Application that examines hearing with Thai words processing that the public can use to screen dementia by themselves before consulting physicians to help prevent and reduce future risk of dementia.

FSU psychologist receives $3.7 million grant to combat anxiety in older adults with Alzheimer’s, cognitive impairment

For the more than 6 million Americans living with Alzheimer’s disease, related dementias, or mild cognitive impairment, anxiety is often an accompanying challenge. A Florida State University psychologist has received a five-year, $3.7 million grant from the National Institute on Aging to study intervention techniques that aim to combat anxiety in these groups and improve quality of life.

Study Shows African Americans and Hispanics Have Greater Vulnerability to Alzheimer’s Because of Vascular Risks, Socioeconomic Factors

African Americans and Hispanics face higher risk for Alzheimer’s disease than whites in the United States, but the reason may not be solely race or ethnicity, new research shows. Instead, those minority groups are more vulnerable because of lifelong inequities in socioeconomic factors such as income, health insurance, and access to medical care that lead to an accumulation of vascular risk factors in midlife and late life, including diabetes, hypertension, and obesity.

Study Shows African Americans and Hispanics Have Greater Vulnerability to Alzheimer’s Because of Vascular Risks, Socioeconomic Factors

James E. Galvin, M.D., M.P.H., a professor of neurology, psychology and behavioral sciences and founding director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine. His team recently published a study titled, “Exploring…

Study yields clues to why Alzheimer’s disease damages certain parts of the brain

A study by researchers at Washington University School of Medicine in St. Louis yields clues to why certain parts of the brain are particularly vulnerable to Alzheimer’s damage. It comes down to the gene APOE, the greatest genetic risk factor for Alzheimer’s disease. The parts of the brain where APOE is most active are the areas that sustain the most damage, they found.

Today: ANA2022 Media Roundtable to Spotlight Latest in Neuro Research

As the American Neurological Association’s 147th Annual Meeting wraps up today, October 25, the ANA is holding a Media Roundtable at 11 a.m. U.S. Central for reporters to access the latest developments in neurology and neuroscience.

American Neurological Association Publishes Research Abstracts for ANA2022, Oct. 22–25 in Chicago

Abstracts of breaking research in neurology and neuroscience, to be presented at the 2022 American Neurological Association Annual Meeting Oct. 22-25, are now available in Annals of Neurology and on the ANA2022 website.